# Noradrenergic Activity, Cognition and Major Depressive Disorder

> **NCT02470026** · NA · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 131 (actual)

## Conditions studied

- Major Depressive Disorder
- Early Life Trauma

## Interventions

- **DRUG:** yohimbine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02470026
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2017-11
- **Final completion:** 2018-10
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02470026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02470026, "Noradrenergic Activity, Cognition and Major Depressive Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02470026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*